The 2023 data indicate that U.S. sales and distribution of medically important antimicrobial drugs approved for use in food-producing animals decreased by 2% between 2022 and 2023. This represents a 37% decrease in sales since the sales peaked in 2015.
Medically important antimicrobial drugs approved for use in swine reached over 2.68 million kg in 2023, a similar volume to 2022 and down 14% from 2016.


October 10, 2024/ FDA/ United States.
https://www.fda.gov